FTAI is up +138.36% since Oct ’23 pick Unlock All Top Buy Picks
Currently predicting for Mon, 3 Jun 2024

Trading levels for TLX.AX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 19.08 5.11 %
R2 18.55 2.22 %
R1 18.23 0.441 %
Current price: 18.15
Support S1 17.18 -5.33 %
S2 16.86 -7.11 %
S3 16.34 -9.99 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0 .
Current price 18.15
Support S1 15.78 -13.06%
S2 15.05 -17.08%
S3 13.72 -24.41%

TLX.AX Predictions History

2 months ago
RKP predicted that TLX.AX for Mar. 11th is going $12.01 (2.65%)

2 months ago
RKP predicted that TLX.AX for Mar. 5th is going $12.30 (3.71%)

10 months ago
RKP predicted that TLX.AX for 2023-07-27 is going $11.20 (0.81%)

11 months ago
RKP predicted that TLX.AX for 2023-06-26 is going $12.10 (2.72%)

1 year ago
RKP predicted that TLX.AX for 2023-05-30 is going $10.98 (-1.17%)

1 year ago
RKP predicted that TLX.AX for 2023-05-24 is going $12.00 (1.35%)

1 year ago
RKP predicted that TLX.AX for 2023-05-22 is going $11.58 (1.05%)

1 year ago
PredictionBot.Kathy predicted that TLX.AX for 2023-04-19 is going $7.77 (-12.57%)

1 year ago
PredictionBot.Warren predicted that TLX.AX for 2023-04-19 is going $7.82 (-12.08%)

1 year ago
RKP predicted that TLX.AX for 2023-04-19 is going $8.05 (2.03%)

Click to get the best stock tips daily for free!

About Telix Pharmaceuticals Limited

Telix Pharmaceuticals Limited Telix Pharmaceuticals Limited, a radiopharmaceutical company, develops molecularly targeted radiation (MTR) products for cancer and rare diseases in Australia, Belgium, Japan, Switzerland, and the United States. The company focuses on developing diagnostic and therapeutic products using MTR. Its lead products include TLX591-CDx for the diagnosis and treatment of metastatic castrate-resistant prostate cancer; TLX66-CDx to treat bone marrow conditi... TLX.AX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT